JAMA Neurology,
No consistent evidence of a difference in the progression of Alzheimer disease-related neurodegeneration between intensive and…
No consistent evidence of a difference in the progression of Alzheimer disease-related neurodegeneration between intensive and…
There is no meaningful difference in MRI biomarkers of Alzheimer disease between intensive and standard blood pressure treatment.
Intensive systolic #bloodpressure control was not associated with changes in MRI biomarkers of #Alzheimersdisease compared with…